Skip to main content
SpringerLink
Log in

Diarrhö unter Immunsuppression

  • Chapter
  • First Online:
Gastrointestinale und hepatobiliäre Infektionen

  • 277 Accesses

Zusammenfassung

Die ursächlichen Erreger, aber auch die klinische Ausprägung können sich bei immunkompromittierten Patienten in hohem Maße von denen immunkompetenter Patienten unterscheiden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Cant A, Cole T (2010) Infections in the immunocompromised. Adv Exp Med Biol 659:1–18

    Article  PubMed  Google Scholar 

  2. Mcgrath B, Broadhurst M, Roman C (2020) Infectious disease considerations in immunocompromised patients. Jaapa 2010(33):16–25

    Google Scholar 

  3. Amaya-Uribe L, Rojas M, Azizi G et al (2019) Primary immunodeficiency and autoimmunity: A comprehensive review. J Autoimmun 99:52–72

    Article  CAS  PubMed  Google Scholar 

  4. Cantoni N, Recher M (2014) Primary and secondary immunodeficiencies. Ther Umsch 71:31–43

    Article  PubMed  Google Scholar 

  5. Krones E, Högenauer C (2012) Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am 41:677–701

    Article  PubMed  Google Scholar 

  6. Feasy NA, Healy P, Gordon MA (2011) Review article: The aetiology, investigation and management of diarrhoea in the HIV-positive patient. Aliment Pharmacol Ther 34:587–603

    Article  Google Scholar 

  7. Horsburgh CR (1991) Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 324:1332–1338

    Google Scholar 

  8. Benson CA, Williams PL, Currier JS et al (2003) A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis 37:1234–1243

    Article  CAS  PubMed  Google Scholar 

  9. Karakousis PC, Moore RD, Chaisson RE (2004) Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis 4:557–565

    Article  PubMed  Google Scholar 

  10. Gerace E, Lo Presti VD, Biondo C (2019) Cryptosporidium infection: Epidemiology, pathogenesis, and differential diagnosis. Eur J Microbiol Immunol 9:119–123

    Google Scholar 

  11. Chen XM, Keithly JS, Paya CV, Larusso NF (2002) Cryptosporidiosis. N Engl J Med 346:1723–1731

    Article  PubMed  Google Scholar 

  12. Iroh Tam P-Y, Chisala M, Nyangulu W et al (2021) Respiratory cryptosporidiosis in Malawian children with diarrheal disease. PLoS Negl Trop Dis 15:e0009643–e0009643

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Sponseller JK, Griffiths JK, Tzipori S (2014) The evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalation. Clin Microbiol Rev 27:575–586

    Article  PubMed  PubMed Central  Google Scholar 

  14. Maggi P, Larocca AM, Quarto M et al (2000) Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 19:213–217

    Article  CAS  PubMed  Google Scholar 

  15. Sparks H, Nair G, Castellanos-Gonzales A, White AC (2015) Treatment of Cryptosporidium: What we know, gaps, and the way forward. Curr Trop Med Rep 2:181–187

    Google Scholar 

  16. Almeria S, Cinar HN, Dubey JP (2019) Cyclospora cayetanensis and Cyclosporiasis: An update. Microorganisms, 7

    Google Scholar 

  17. Ortega YR, Sanchez R (2010) Update on Cyclospora cayetanensis, a food-borne and waterborne parasite. Clin Microbiol Rev 23:218–234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Dubey JP, Almeria S (2019) Cystoisospora belli infections in humans: the past 100 years. Parasitology 146:1490–1527

    Article  CAS  PubMed  Google Scholar 

  19. Verdier RI, Fitzgerald DW, Johnson WD, Pape JW (2000) Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Ann Intern Med 132:885–888

    Google Scholar 

  20. Petrignani M, Verhoef L, De Graaf M et al (2018) Chronic sequelae and severe complications of norovirus infection: A systematic review of literature. J Clin Virol 105:1–10

    Article  PubMed  Google Scholar 

  21. Caplan MR, Wilson EMP, Schechter M et al (2021) High prevalence of gastrointestinal manifestations among Cytomegalovirus end-organ disease in the combination antiretroviral era. J Virus Erad 7:100052

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Dieterich DT, Rahmin M (1991) Cytomegalovirus colitis in AIDS: Presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr 4(1):S29-35

    PubMed  Google Scholar 

  23. Chamberlain RS, Atkins S, Saini N, White JC (2000) Ileal perforation caused by cytomegalovirus infection in a critically ill adult. J Clin Gastroenterol 30:432–435

    Article  CAS  PubMed  Google Scholar 

  24. Schmidt-Hieber M, Bierwirth J, Buchheidt D et al (2018) Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 97:31–49

    Article  CAS  PubMed  Google Scholar 

  25. Yust, I., FOox, Z., Burke, M. et al (2004) Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994–2001. Eur J Clin Microbiol Infect Dis 23:550–559

    Google Scholar 

  26. Salzberger B, Hartmann P, Hanses F et al (2005) Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy. Infection 33:345–349

    Article  CAS  PubMed  Google Scholar 

  27. Lindemans CA, Leen AM, Boelens JJ (2010) How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 116:5476–5485

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gu J, Su QQ, Zuo TT, Chen YB (2021) Adenovirus diseases: A systematic review and meta-analysis of 228 case reports. Infection 49:1–13

    Article  CAS  PubMed  Google Scholar 

  29. Matthes-Martin S, Boztug H, Lion T (2013) Diagnosis and treatment of adenovirus infection in immunocompromised patients. Expert Rev Anti Infect Ther 11:1017–1028

    Article  CAS  PubMed  Google Scholar 

  30. Heyworth MF (2017) Genetic aspects and environmental sources of microsporidia that infect the human gastrointestinal tract. Trans R Soc Trop Med Hyg 111:18–21

    Article  PubMed  Google Scholar 

  31. Han B, Pan G, Weiss LM (2021) Microsporidiosis in Humans. Clin Microbiol Rev 34:e0001020

    Article  PubMed  Google Scholar 

  32. Anane S, Attouchi H (2010) Microsporidiosis: Epidemiology, clinical data and therapy. Gastroenterol Clin Biol 34:450–464

    Article  CAS  PubMed  Google Scholar 

  33. Michlmayr, D., Alves De Sousa, L., Müller, L. et al (2022) Incubation Period, spore shedding duration, and symptoms of Enterocytozoon bieneusi genotype C infection in a foodborne outbreak in Denmark, 2020. Clin Infect Dis 75(3):468–475. Published online 2021 Nov 13. https://doi.org/10.1093/cid/ciab949

  34. Ramanan P, Pritt BS (2014) Extraintestinal microsporidiosis. J Clin Microbiol 52:3839–3844

    Article  PubMed  PubMed Central  Google Scholar 

  35. Molina JM, Tourneur M, Sarfati C et al (2002) Fumagillin treatment of intestinal microsporidiosis. N Engl J Med 346:1963–1969

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik 2, Schwerpunkt Infektiologie, Universitätsklinikum Frankfurt, Frankfurt am Main, Deutschland

    Imke Wieters & Maria J. G. T. Vehreschild

Authors
  1. Imke Wieters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria J. G. T. Vehreschild
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria J. G. T. Vehreschild .

Editor information

Editors and Affiliations

  1. Klinik für Innere Medizin 2, Diakonie-Klinikum Schwäbisch Hall, Schwäbisch Hall, Deutschland

    Markus Menges

  2. Diakonie Klinikum Neunkirchen gemeinnützige GmbH, Neunkirchen, Deutschland

    Jens M. Kittner

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wieters, I., Vehreschild, M.J.G.T. (2023). Diarrhö unter Immunsuppression. In: Menges, M., Kittner, J.M. (eds) Gastrointestinale und hepatobiliäre Infektionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-66959-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-66959-4_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-66958-7

  • Online ISBN: 978-3-662-66959-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation